Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UKLG LY09 Trial of Initial Chemotherapy for Advanced Hodgkin's Disease
NCT00003421Phase 3Completed
- Sponsor
- Medical Research Council
- Start
- Jun 1998
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of chlorambucil, vinblastine, procarbazine, prednisolone, doxorubicin and 3 more in Hodgkin lymphoma (HL) (2 arms), sponsored by Medical Research Council. Primary endpoint: Event-Free Survival at 5 years. Started Jun 1998; status: completed.
02
Drugs
chlorambucilvinblastineprocarbazineprednisolonedoxorubicin
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00003421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003421.